The present study aimed to investigate the relationship between serum oxytocin (OT) and logical memory among older people in rural Japan.
Methods:
This was a cross-sectional study using a survey conducted from October 2009 through March 2011. Most of the study was conducted as part of a national prevalence survey of dementia in Japan. The final sample comprised 385 community-dwelling people aged 65 years or older living in rural Japan. The mean age and standard deviation were 75.7 ± 6.76 years (144 men, mean age 75.0 ± 6.48 years; 241 women, mean age 76.2 ± 6.91 years). The participants underwent screening examinations for a prevalence survey of dementia. The screening examinations were the Mini-Mental State Examination, Clinical Dementia Rating, and “logical memory A” from the Wechsler Memory Scale–Revised (WMSR). We used the WMSR Logical Memory II delayed recall score (LM II-DR) to assess logical memory. Levels of serum OT were obtained using the enzyme immunoassay method.
Results:
Serum OT levels were significantly higher among women than men. The present study revealed that serum OT levels were positively associated with LM II-DR in older women living in rural Japan in multiple linear regression analyses.
Conclusions:
The present results suggested a positive correlation between OT and logical memory in older women living in rural Japan.
CrockfordCDeschnerTZieglerTEWittigRM. Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review. Front Behav Neurosci. 2014;11(8):68.
2.
FeldmanR. Oxytocin and social affiliation in humans. Horm Behav. 2012;61(3):380–391.
3.
Meyer-LindernbergADomesGKirschPHeinrichsM. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12(9):524–538.
4.
WeismanOZagoory-SharonOSchneidermanIGordonIFeldmanR. Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety. Psychoneuroendocrinology. 2013;38(5):694–701.
5.
TaylorSEGonzagaGCKleinLCHuPGreendaleGASeemanTE. Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosom Med. 2006;68(2):238–245.
6.
TaylorSESaphire-BernsteinSSeemanTE. Are Plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?Psychol Sci. 2010;21(1):3–7.
7.
ChiniBLeonzinoMBraidaDSalaM. Learning about oxytocin: pharmacologic and behavioral issues. Biol Psychiatry. 2014;76(5):360–366.
8.
EbnerNCKaminHDiazVCohenRAMacDonaldK. Hormones as “difference makers” in cognitive and socioemotional aging processes. Front Psychol. 2015;5:1595.
9.
BarrazaJAGrewalNSRopackiSPerezPGonzalezAZakPJ. Effects of a 10-day oxytocin trial in older adults on health and well-being. Exp Clin Psychopharmacol. 2013;21(2):85–92.
GraingerSAHenryJDSteinvikHRVanmanEJRendellPGLabuschagneI. Intranasal oxytocin does not reduce age-related difficulties in social cognition. Horm Behav. 2018;99:25–34.
12.
GraingerSAHenryJDSteinvikHRVanmanEJ. Intranasal oxytocin does not alter initial perceptions of facial trustworthiness in younger or older adults. J Psychopharmacol. 2019;33(2):250–254.
13.
EbnerNCMauraGMMacdonaldKWestbergLFischerH.Oxytocin and socioemotional aging: current knowledge and future trends. Front Hum Neurosci. 2013;7:487.
14.
HuffmeijerRVan IjzendoornMHBakermans-KranenburgMJ. Ageing and oxytocin: a call for extending human oxytocin research to ageing populations—a mini-review. Gerontology. 2013;59(1):32–39.
15.
ArlettiRBenelliAPoggioliRLuppiPMenozziBBertoliniA. Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin. Neuropeptides. 1995;29(3):177–182.
16.
FliersESwaabDF. Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat. Peptides. 1983;4(2):165–170.
17.
ArsenijevicYDreifussJJValletPMargueratATribolletE. Reduced binding of OT in the rat brain during aging. Brain Res. 1995;698(1-2):275–279.
18.
MelisMRMauriAArgiolasA. Opposite changes in the content of oxytocin- and vasopressin-like immunoreactive peptides in the rat thymus during aging. Regul Pept. 1995;59(3):335–340.
19.
NorthWGHarbaughRReederT. An evaluation of human neurophysin production in Alzheimer’s disease: preliminary observations. Neurobiol Aging. 1992;13(2):261–265.
20.
MazurekMFBealMFBirdEDMartinJB. Oxytocin in Alzheimer’s disease: postmortem brain levels. Neurology. 1987;37(6):1001–1003.
21.
WierdaMGoudsmitEVan der WoudePF, et al.Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer’s disease. Neurobiol Aging. 1991;12(5):511–516.
22.
EbnerNCHortaMLinTFeifelDFischerHCohenRA. Oxytocin modulates meta-mood as a function of age and sex. Front Aging Neurosci. 2015;7:175.
23.
EbnerNCChenHPorgesE, et al.Oxytocin’s effect on resting-state functional connectivity varies by age and sex. Psychoneuroendocrinology. 2016;69:50–59.
24.
LinYTHsuKS. Oxytocin receptor signaling in the hippocampus: role in regulating neuronal excitability, network oscillatory activity, synaptic plasticity and social memory. Prog Neurobiol. 2018;171:1–14.
25.
ApostolovaLGMorraJHGreenAE, et al.Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage. 2010;51(1):488–499.
26.
IkejimaCHisanagaAMeguroK, et al.Multicenter population-based dementia prevalence survey in Japan: a preliminary report. Psychogeriatrics. 2012;12(2):120–123.
27.
LiGYWatanabeIKunitakeY, et al.Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population. Psychiatry Clin Neurosci. 2008;62(5):562–567.
28.
WatanabeILiGYImamuraY, et al.Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study. Psychiatry Res. 2012;195(3):125–128.
29.
WatanabeILiGYImamuraY, et al.Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community: 3-year follow-up study. Int J Geriatr Psychiatry. 2012;27(3):321–326.
30.
NabetaHMizoguchiYMatsushimaJ, et al.Association of salivary cortisol levels and later depressive state in elderly people living in a rural community: a 3-year follow-up study. J Affect Disord. 2014;158:85–89.
31.
MatsushimaJKawashimaTNabetaH, et al.Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study. J Affect Disord. 2015;173:9–14.
32.
ImamuraYMizoguchiYNabetaH, et al.Belief in life after death, salivary 3-methoxy-4-hydoroxyphenylglycol, and well-being among older people without cognitive impairment dwelling in rural Japan. Int J Geriatr Psychiatry. 2015;30(3):256–264.
33.
ImamuraYMizoguchiYNabetaH, et al.An association between belief in life after death and serum oxytocin in older people in rural Japan. Int J Geriatr Psychiatry. 2017;32(1):102–109.
34.
FolsteinMFFolsteinSEMcHughPR. Mini-Mental State; a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
35.
MorrisJC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414.
36.
WechslerD. Wechsler Memory Scale—Revised Manual. San Antonio, TX: The Psychological Corporation; 1987.
37.
AitaCMizoguchiYYamamotoM, et al.Oxytocin levels and sex differences in autism spectrum disorder with severe intellectual disabilities. Psychiatry Res. 2019;273:67–74.
38.
RubinLHCarterCSDrogosLLPournajafi-NazarlooHSweeneyJAMakiPM. Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. Schizophr Res. 2015;166(1-3):269–275.
39.
RubinLHWehringHJDemyanovichH, et al.Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia. Schizophr Res. 2018;195:409–411.
40.
BreuilVFontasEChapurlatR, et al.Oxytocin and bone status in men: analysis of the MINOS cohort. Osteoporos Int. 2015;26(12):2877–2882.
41.
BreuilVPanaia-FerrariPFontasE, et al.Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohort. J Clin Endocrinol Metab. 2014;99(4):E634–641.
42.
SzetoAMcCabePMNationDA, et al.Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med. 2011;73(5):393–400.
43.
McCulloughMEChurchlandPSMendezAJ. Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?Neurosci Biobehav Rev. 2013;37(8):1485–1492.
44.
LengGSabatierN. Measuring oxytocin and vasopressin: bioassays, immunoassays and random numbers. J Neuroendocrinol. 2016;28(10).
45.
EngelSLauferSMillerRNiemeyerHKnaevelsrudCSchumacherS. Demographic, sampling- and assay-related confounders of endogenous oxytocin concentrations: a systematic review and meta-analysis. Front Neuroendocrinol. 2019;54:100775.
